Insider Trading History of Giordano Natasha

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Giordano Natasha since 2014. This trader's CIK number is 1315585. At the time of last reporting, Giordano Natasha was the Chief Executive Officer of Plx Pharma Inc.. (stock ticker symbol PLXP). Also see all insider trading activities at Plx Pharma Inc..

Note that in the past Giordano Natasha also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Plx Pharma Inc. (PLXP) by Giordano Natasha

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 PLXP 4,100 $14,977 0 $0 0 $0

Yearly summary of insider trading at Aceto Corp (ACET) by Giordano Natasha

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 ACET 0 $0 2,164 $45,281 0 $0
2014 ACET 0 $0 6,000 $111,922 0 $0


Insider trading activities at 2 companies by Giordano Natasha:

1. Plx Pharma Inc. (PLXP)

2. Aceto Corp (ACET)

Table 1. Insider trading of Plx Pharma Inc. (PLXP) by Giordano Natasha

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-15 PLXP Buy 4,100 3.65 14,977

Table 2. Insider trading of Aceto Corp (ACET) by Giordano Natasha

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-03-04 ACET Sale 2,164 20.93 45,281
2014-09-09 ACET Sale 1,453 21.94 31,878
2014-06-06 ACET Sale 1,160 17.28 20,044
2014-06-02 ACET Sale 1,149 17.43 20,029
2014-05-23 ACET Sale 1,128 17.91 20,202
2014-05-21 ACET Sale 1,110 17.81 19,769

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Giordano Natasha (Chief Executive Officer of Plx Pharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.